Screening in early pregnancy for pre-eclampsia using Down syndrome Quadruple test markers

Prenatal Diagnosis

Volumn 26, Issue 6, 2006, Pages 559-564

  Wald, Nicholas J ^a   Morris, Joan K ^a   Ibison, Judith ^a   Wu, Tiesheng ^a   George, Lynne M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Down syndrome markers; Pre eclampsia screening; Quadruple test

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN A;

ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; UNITED KINGDOM;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INHIBINS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS;

EID: 33745635756     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1459     Document Type: Article

References (18)

1. Aquilina J, Maplethorpe R, Ellis P, Harrington K. 2000. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia. Placenta 21: 487-492.
2. Ay E, Kavak ZN, Elter K, Gokaslan H, Pekin T. 2005. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. Aust N Z J Obstet Gynaecol 45: 283-288.
3. Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM. 2005. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind placebo controlled trial. Am J Obstet Gynecol 192: 520-521.
4. Chappell LC, Seed PT, Briley AL, et al. 1999. Effective anti-oxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354: 810-816.
5. Conde-Agudelo A, Villar J, Lindheimer M. 2004. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 104: 1367-1391.
6. Douglas KA, Redman CWG. 1994. Eclampsia in the United Kingdom. BMJ 309: 1395-1399.
7. Duckitt K, Harrington D. 2005. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330: 549-550.
8. Dugoff L, Hobbins JC, Malone FD, et al. 2005. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 106: 260-267.
9. Duley L, Henderson-Smart DJ, Knight M, King JF. 2003. Anti-platelet agent for preventing pre-eclampsia and its complications. The cochrane database of systematic reviews. Issue 4; Article no: CD004659, DOI: 10.1002/14651858. CD004659.
10. Lambert-Messerlian GM, Silver HM, Petraglia F, et al. 2000. Second-trimester levels in maternal serum human chorionic gonadotrophin and inhibin A as predictors of pre-eclampsia in the third trimester of pregnancy. J Soc Gynecol Investig 7: 170-174.
11. Milne F, Redman C, Walker J, et al. 2005. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 330: 576-580.
12. Sibai B, Dekker G, Kupfermine M. 2005. Pre-eclampsia. Lancet 365: 785-799.
13. Wald NJ, Morris JK. 2001. Multiple marker second trimester serum screening for pre-eclampsia. J Med Screen 8: 65-68.
14. Wald NJ, Hackshaw AK, Frost CD. 1999. When can a risk factor be used as a worthwhile screening test? BMJ 319: 1562-1565.
15. Wald NJ, Cuckle HS, Densem JW, et al. 1988. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297: 883-887.
16. Why Mothers Die 2000-2002. 2004. Report on confidential enquiries into maternal deaths in the United Kingdom. RCOG: London.
17. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH, for the Vitamins in Pre-eclampsia (VIP) Trial Consortium. 2006. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367: 1145-54.
18. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS, for the ACTS Study Group. 2006. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354: 1796-806.